Researchers at the Icahn School of Medicine at Mount Sinai and the Mount Sinai Tisch Cancer Center have discovered a ...
Imaging studies of more than 27,000 adults link a healthier thymus on CT scans with a longer life and lower risks of ...
Researchers at the Icahn School of Medicine at Mount Sinai and the Mount Sinai Tisch Cancer Center have discovered a biological pathway that helps ...
After repeated unsuccessful cancer treatments, even the strongest patients can lose hope. But former University of Virginia ...
Researchers at the Icahn School of Medicine at Mount Sinai and the Mount Sinai Tisch Cancer Center have discovered a ...
A new international study has found that combining two cancer medicines may significantly slow the growth of a dangerous form ...
With the MAHA movement poised to introduce a lot more "integrative" or "complementary and alternative" treatments into ...
That superhero is a gene called TP53, and for decades scientists have known it as the “guardian of the genome.” In a healthy ...
As artificial intelligence (AI) tools continue to proliferate, they are becoming a go-to search tool for patients, providers, ...
A gene called FOXJ1 may drive resistance to taxane chemotherapy during treatment for advanced prostate cancer, according to a new study led by investigators at Weill Cornell Medicine and Beth Israel ...
On a typical day, they greet farmers bringing them ticks, real estate agents with mysterious roaches and anxious homeowners ...
How can I deliver care not just to the 100,000 patients who might have cancer but to the 500,000 patients who may be at risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results